BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99-109. [PMID: 24634588 DOI: 10.2147/CLEP.S37357] [Cited by in Crossref: 109] [Cited by in F6Publishing: 244] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 2016;1865:245-54. [PMID: 26980625 DOI: 10.1016/j.bbcan.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
2 Zhou H, Yuan Y, Qian H. Expression of STAT3 and vasculogenic mimicry in gallbladder carcinoma promotes invasion and metastasis. Exp Ther Med 2021;22:738. [PMID: 34055055 DOI: 10.3892/etm.2021.10170] [Reference Citation Analysis]
3 Park JO, Oh DY, Hsu C, Chen JS, Chen LT, Orlando M, Kim JS, Lim HY. Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review. Cancer Res Treat 2015;47:343-61. [PMID: 25989801 DOI: 10.4143/crt.2014.308] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
4 Sun LJ, Guan A, Xu WY, Liu MX, Yin HH, Jin B, Xu G, Xie FH, Xu HF, Du SD, Xu YY, Zhao HT, Lu X, Sang XT, Yang HY, Mao YL. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma. World J Gastrointest Oncol 2020;12:1014-30. [PMID: 33005295 DOI: 10.4251/wjgo.v12.i9.1014] [Reference Citation Analysis]
5 Xie Y, Jiang Y, Yang XB, Wang AQ, Zheng YC, Wan XS, Sang XT, Wang K, Zhang DD, Xu JJ, Li FG, Zhao HT. Response of BRCA1-mutated gallbladder cancer to olaparib: A case report. World J Gastroenterol 2016;22:10254-9. [PMID: 28028375 DOI: 10.3748/wjg.v22.i46.10254] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
6 Mao W, Deng F, Wang D, Gao L, Shi X. Treatment of advanced gallbladder cancer: A SEER-based study. Cancer Med 2020;9:141-50. [PMID: 31721465 DOI: 10.1002/cam4.2679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bharti S, Bharti JN, Puranik A, Anju G. Incidental Finding of Primary Mucinous Adenocarcinoma of Gall Bladder: a Histopathological Diagnosis. J Gastrointest Cancer 2021;52:320-4. [PMID: 32529395 DOI: 10.1007/s12029-020-00435-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ren T, Li Y, Zhang X, Geng Y, Shao Z, Li M, Wu X, Wang XA, Liu F, Wu W, Shu Y, Bao R, Gong W, Dong P, Dang X, Liu C, Liu C, Sun B, Liu J, Wang L, Hong D, Qin R, Jiang X, Zhang X, Xu J, Jia J, Yang B, Li B, Dai C, Cao J, Cao H, Tao F, Zhang Z, Wang Y, Jin H, Cai H, Fei Z, Gu J, Han W, Feng X, Fang L, Zheng L, Zhu C, Wang K, Zhang X, Li X, Jin C, Qian Y, Cui Y, Xu Y, Wang X, Liu H, Hua Y, Liu C, Hao J, Wang C, Li Q, Li X, Liu J, Li M, Qiu Y, Wu B, Zheng J, Chen X, Zhu H, Hua K, Yan M, Wang P, Zang H, Ma X, Hong J, Liu Y. Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study. BMJ Open 2021;11:e038634. [PMID: 33593763 DOI: 10.1136/bmjopen-2020-038634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xue C, He Y, Hu Q, Yu Y, Chen X, Chen J, Ren F, Li J, Ren Z, Cui G, Sun R. Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer. Cancer Manag Res 2018;10:5101-12. [PMID: 30464610 DOI: 10.2147/CMAR.S184381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Shi Y, Chen J, Chen H, Hong X. Sarcomatoid carcinoma of the gallbladder: a case report. J Int Med Res 2020;48:300060520935283. [PMID: 32589472 DOI: 10.1177/0300060520935283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chandra P, Dixit R, Pratap A, Mishra S, Mishra R, Shukla VK. Analysis of SET and MYND Domain-Containing Protein 3 (SMYD3) Expression in Gallbladder Cancer: a Pilot Study. Indian J Surg Oncol 2021;12:111-7. [PMID: 33994736 DOI: 10.1007/s13193-020-01168-6] [Reference Citation Analysis]
12 Sicklick JK, Fanta PT, Shimabukuro K, Kurzrock R. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design. Cancer Metastasis Rev. 2016;35:263-275. [PMID: 26857926 DOI: 10.1007/s10555-016-9602-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
13 Lee SH, Kim JM, Lee DG, Lee J, Park JG, Han TS, Cho HS, Cho YL, Bae KH, Park YJ, Lee SJ, Lee MS, Huh YM, Jo DY, Yun HJ, Jeon HJ, Kim N, Joo M, Kim JS, Lee HJ, Min JK. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation. Cell Death Differ 2021;28:968-84. [PMID: 32989241 DOI: 10.1038/s41418-020-00628-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, McGlynn KA, Adami HO, Berrington de González A, Beane Freeman LE, Bernstein L, Buring JE, Freedman ND, Gao YT, Giles GG, Gunter MJ, Jenab M, Liao LM, Milne RL, Robien K, Sandler DP, Schairer C, Sesso HD, Shu XO, Weiderpass E, Wolk A, Xiang YB, Zeleniuch-Jacquotte A, Zheng W, Gapstur SM. Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev 2017;26:597-606. [PMID: 28314823 DOI: 10.1158/1055-9965.EPI-16-0796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
15 Matsubayashi H, Matsui T, Sugiura T, Makuuchi R, Kaneko J, Satoh J, Satoh T, Fujie S, Ishiwatari H, Sasaki K, Ono H. A Large Carcinosarcoma of the Gallbladder Accompanied by Pancreaticobiliary Maljunction: A Case with a Six-year Survival. Intern Med 2019;58:2809-17. [PMID: 31243200 DOI: 10.2169/internalmedicine.2783-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Deng Y, Zhang F, Yu X, Huo CL, Sun ZG, Wang S. Prognostic Value Of Preoperative Systemic Inflammatory Biomarkers In Patients With Gallbladder Cancer And The Establishment Of A Nomogram. Cancer Manag Res 2019;11:9025-35. [PMID: 31695494 DOI: 10.2147/CMAR.S218119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
17 Signorelli C, Marrucci E, Cristi E, Pastorelli A, Cardello P, Chilelli MG, Zampaletta C, Ruggeri EM. Colon metastasis from recurrent gallbladder cancer: a case report. AME Case Rep 2021;5:21. [PMID: 34312600 DOI: 10.21037/acr-20-167] [Reference Citation Analysis]
18 Swain B, Otta S, Sahu MK, Uthansingh K. Fasciola hepatica association with gallbladder malignancy: A rare case report. Trop Parasitol 2021;11:42-5. [PMID: 34195060 DOI: 10.4103/tp.TP_25_20] [Reference Citation Analysis]
19 Li K, Tang J, Hou Y. LncRNA GATA6-AS inhibits cancer cell migration and invasion in gallbladder cancer by downregulating miR-421. Onco Targets Ther 2019;12:8047-53. [PMID: 31632058 DOI: 10.2147/OTT.S212231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
20 Lin Y, Chen H, Pan F. Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis. Med Sci Monit 2021;27:e929106. [PMID: 33784268 DOI: 10.12659/MSM.929106] [Reference Citation Analysis]
21 Kim M, Kim H, Han Y, Sohn H, Kang JS, Kwon W, Jang JY. Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers (Basel) 2021;13:1089. [PMID: 33806265 DOI: 10.3390/cancers13051089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hong H, He C, Zhu S, Zhang Y, Wang X, She F, Chen Y. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways. J Exp Clin Cancer Res 2016;35:51. [PMID: 27009073 DOI: 10.1186/s13046-016-0318-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
23 Giannis D, Cerullo M, Moris D, Shah KN, Herbert G, Zani S, Blazer DG 3rd, Allen PJ, Lidsky ME. Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors. Cancers (Basel) 2021;13:547. [PMID: 33535552 DOI: 10.3390/cancers13030547] [Reference Citation Analysis]
24 Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, Li W, Ma L, Wang L. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage. PLoS One 2016;11:e0166361. [PMID: 27846279 DOI: 10.1371/journal.pone.0166361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
25 Du JH, Lu J. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient. J Clin Lab Anal 2019;33:e22684. [PMID: 30461064 DOI: 10.1002/jcla.22684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Chen P, Wang Y, Li J, Bo X, Wang J, Nan L, Wang C, Ba Q, Liu H, Wang H. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing. Clin Transl Med 2021;11:e462. [PMID: 34185421 DOI: 10.1002/ctm2.462] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Li HF, Wang XA, Xiang SS, Hu YP, Jiang L, Shu YJ, Li ML, Wu XS, Zhang F, Ye YY, Weng H, Bao RF, Cao Y, Lu W, Dong Q, Liu YB. Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells. Drug Des Devel Ther 2015;9:3017-30. [PMID: 26109845 DOI: 10.2147/DDDT.S84448] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
28 Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol. 2016;22:1335-1347. [PMID: 26819503 DOI: 10.3748/wjg.v22.i4.1335] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
29 Olthof PB, Metman MJH, de Krijger RR, Scheepers JJ, Roos D, Dekker JWT. Routine Pathology and Postoperative Follow-Up are Not Cost-Effective in Cholecystectomy for Benign Gallbladder Disease. World J Surg 2018;42:3165-70. [PMID: 29696323 DOI: 10.1007/s00268-018-4619-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
30 Zhai T, Zhang X, Hei Z, Jin L, Han C, Ko AT, Yu X, Wang J. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation. Front Pharmacol 2021;12:628621. [PMID: 33679411 DOI: 10.3389/fphar.2021.628621] [Reference Citation Analysis]
31 Aldossary MY, Alayed AA, Amr S, Alqahtani MS. Primary squamous cell carcinoma of the gallbladder: Report of a rare neoplasm from the Eastern Province of Saudi Arabia. Int J Surg Case Rep 2018;51:186-9. [PMID: 30176555 DOI: 10.1016/j.ijscr.2018.08.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Al-Fayea T, Alzahrani M, Almaghrabi H, Alghamdi A, Mohammed K. Recurrent Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm in the Gallbladder: A Case Report. Case Rep Oncol 2021;14:411-7. [PMID: 33776736 DOI: 10.1159/000513031] [Reference Citation Analysis]
33 Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Klümpen HJ, Lohse AW, Nashan B, Primrose J, Schrum S, Shannon J, Vettorazzi E, Wege H. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC Cancer 2015;15:564. [PMID: 26228433 DOI: 10.1186/s12885-015-1498-0] [Cited by in Crossref: 101] [Cited by in F6Publishing: 82] [Article Influence: 16.8] [Reference Citation Analysis]
34 Tian L, Lu Y, Yang T, Deng Z, Xu L, Yao W, Ma C, Li X, Zhang J, Liu Y, Wang J. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1. Redox Biol 2019;22:101149. [PMID: 30822690 DOI: 10.1016/j.redox.2019.101149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Li ZM, Wu ZX, Han B, Mao YQ, Chen HL, Han SF, Xia JL, Wang LS. The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget 2016;7:43669-79. [PMID: 27248320 DOI: 10.18632/oncotarget.9664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
36 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Reference Citation Analysis]
37 Amarti LE, Faouzi H, Salmi N, Ettahri H, Elghissassi I, Mrabti H, Errihani H. Breast metastasis from recurrent gallbladder adenocarcinoma: a case report with review of the literature. J Gastrointest Oncol 2016;7:E77-80. [PMID: 27512606 DOI: 10.21037/jgo.2016.03.08] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Lagenfelt H, Blomstrand H, Elander NO. Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer. Cancers (Basel) 2021;13:3507. [PMID: 34298723 DOI: 10.3390/cancers13143507] [Reference Citation Analysis]
39 He YM, Zhang ZL, Liu QY, Xiao YS, Wei L, Xi C, Nan X. Effect of CLIC1 gene silencing on proliferation, migration, invasion and apoptosis of human gallbladder cancer cells. J Cell Mol Med. 2018;22:2569-2579. [PMID: 29516682 DOI: 10.1111/jcmm.13499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
40 Wang L, Yang M, Guo X, Yang Z, Liu S, Ji Y, Jin H. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4. Cancer Sci 2020;111:1514-27. [PMID: 32030850 DOI: 10.1111/cas.14344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
41 Su L, Wang MM, Xu MR, Wang X, Xia HZ, Zhang M, Zheng L, Zhu YD, Wang MQ, Li P. Banxia Xiexin Decoction () Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review. Chin J Integr Med 2019;25:303-6. [PMID: 30707412 DOI: 10.1007/s11655-019-3152-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Lin W, Tong C, Zhang W, Cen W, Wang Y, Li J, Zhu Z, Yu J, Lu B. Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells. Biomed Res Int 2020;2020:3235786. [PMID: 32923479 DOI: 10.1155/2020/3235786] [Reference Citation Analysis]
43 Ebata N, Fujita M, Sasagawa S, Maejima K, Okawa Y, Hatanaka Y, Mitsuhashi T, Oosawa-Tatsuguchi A, Tanaka H, Miyano S, Nakamura T, Hirano S, Nakagawa H. Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis. Cancers (Basel) 2021;13:733. [PMID: 33578820 DOI: 10.3390/cancers13040733] [Reference Citation Analysis]
44 Liu MC, Jiang L, Hong HJ, Meng ZW, Du Q, Zhou LY, She FF, Chen YL. Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma. Tumour Biol 2015;36:6305-12. [PMID: 25801241 DOI: 10.1007/s13277-015-3316-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
45 Kim BW, Oh CM, Choi HY, Park JW, Cho H, Ki M. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database. Gut Liver 2019;13:104-13. [PMID: 29938462 DOI: 10.5009/gnl18105] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
46 Arslan E, Aksoy T, Dursun N, Gürsu RU, Sevinç MM, Çermik TF. The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas. Turk J Gastroenterol 2020;31:105-12. [PMID: 32141818 DOI: 10.5152/tjg.2020.19410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Fatima N, Srivastava AN, Nigam J, Raza ST, Rizvi S, Siddiqui Z, Kumar V. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study. Asian Pac J Cancer Prev 2019;20:1895-900. [PMID: 31244315 DOI: 10.31557/APJCP.2019.20.6.1895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Mihor A, Tomsic S, Zagar T, Lokar K, Zadnik V. Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies. Radiol Oncol 2020;54:1-13. [PMID: 32074075 DOI: 10.2478/raon-2020-0008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
49 Wan X, Zhang H, Chen C, Yang X, Wang A, Zhu C, Fu L, Miao R, He L, Yang H, Zhao H, Sang X. Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore). 2014;93:e131. [PMID: 25501049 DOI: 10.1097/md.0000000000000131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
50 Xie Y, Lin JZ, Wang AQ, Xu WY, Long JY, Luo YF, Shi J, Liang ZY, Sang XT, Zhao HT. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer. World J Gastroenterol 2017;23:5787-97. [PMID: 28883705 DOI: 10.3748/wjg.v23.i31.5787] [Reference Citation Analysis]
51 Fluxá P, Rojas-Sepúlveda D, Gleisner MA, Tittarelli A, Villegas P, Tapia L, Rivera MT, López MN, Catán F, Uribe M, Salazar-Onfray F. High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival. BMC Cancer 2018;18:243. [PMID: 29499656 DOI: 10.1186/s12885-018-4147-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
52 Chen JB, Pan ZB, Du DM, Qian W, Ma YY, Mu F, Xu KC. Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report. World J Clin Cases 2019;7:2065-74. [PMID: 31423439 DOI: 10.12998/wjcc.v7.i15.2065] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
53 Enyu L, Na W, Chuanzong Z, Ben W, Xiaojuan W, Yan W, Zequn L, Jianguo H, Jiayong W, Benjia L, Cheng P, Min Z, Zongli Z. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer. Oncotarget 2017;8:19467-77. [PMID: 28061445 DOI: 10.18632/oncotarget.14444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
54 González-Domingo M, Lafuente BO, Luca ÁR, Zamorano PK, Mella PG. Impact of lymph nodal stage on gallbladder cancer survival after extended cholecystectomy and adjuvant radiochemotherapy: long-term results from an oncology institute, Chile. Ecancermedicalscience 2021;15:1222. [PMID: 34158826 DOI: 10.3332/ecancer.2021.1222] [Reference Citation Analysis]
55 Cai ZQ, Guo P, Si SB, Geng ZM, Chen C, Cong LL. Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network. Sci Rep. 2017;7:293. [PMID: 28331235 DOI: 10.1038/s41598-017-00491-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
56 Guo R, Qin Y, Shi P, Xie J, Chou M, Chen Y. IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncol Lett 2016;12:4749-55. [PMID: 28105184 DOI: 10.3892/ol.2016.5254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
57 Wiles R, Thoeni RF, Barbu ST, Vashist YK, Rafaelsen SR, Dewhurst C, Arvanitakis M, Lahaye M, Soltes M, Perinel J. Management and follow-up of gallbladder polyps: Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol. 2017;27:3856-3866. [PMID: 28185005 DOI: 10.1007/s00330-017-4742-y] [Cited by in Crossref: 92] [Cited by in F6Publishing: 61] [Article Influence: 23.0] [Reference Citation Analysis]
58 Zhang Y, Zhou T, Han S, Chang J, Jiang W, Wang Z, Li C, Li X. Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study. Int J Clin Oncol 2021;26:1120-9. [PMID: 33666788 DOI: 10.1007/s10147-021-01891-2] [Reference Citation Analysis]
59 Aldossary MY, AlQattan AS, Alghamdi YM, Alayed AA, Alquraish F, AlAnzi OA, Alabdulrahim N, Alateeq A, Alqahtani MS. Surgical outcomes of primary carcinosarcoma of the gallbladder after curative resection: A rare case series. Int J Surg Case Rep 2019;65:32-9. [PMID: 31678697 DOI: 10.1016/j.ijscr.2019.10.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Shen HX, Song HW, Xu XJ, Jiao ZY, Ti ZY, Li ZY, Ren B, Chen C, Ma L, Zhao YL. Clinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centers. Chronic Dis Transl Med. 2017;3:60-66. [PMID: 29063057 DOI: 10.1016/j.cdtm.2017.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
61 Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer. Chin J Cancer 2017;36:85. [PMID: 29084608 DOI: 10.1186/s40880-017-0252-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Das C, Mukhopadhyay M, Subba S, Saha AK, Mukhopadhyay B. Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC). J Lab Physicians 2021;13:29-35. [PMID: 34103877 DOI: 10.1055/s-0041-1726561] [Reference Citation Analysis]
63 Maruyama T, Tomofuji T, Machida T, Kato H, Tsutsumi K, Uchida D, Takaki A, Yoneda T, Miyai H, Mizuno H, Ekuni D, Okada H, Morita M. Association between periodontitis and prognosis of pancreatobiliary tract cancer: A pilot study. Mol Clin Oncol 2017;6:683-7. [PMID: 28515921 DOI: 10.3892/mco.2017.1220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 Lee EC, Park S, Lee SD, Han S, Kim SH. Effects of Sarcopenia on Prognosis After Resection of Gallbladder Cancer. J Gastrointest Surg 2020;24:1082-91. [DOI: 10.1007/s11605-019-04198-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Xiao Z, Shi Z, Hu L, Gao Y, Zhao J, Liu Y, Xu Q, Huang D. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7:738. [PMID: 32042754 DOI: 10.21037/atm.2019.11.112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
66 Lin J, Dong K, Bai Y, Zhao S, Dong Y, Shi J, Shi W, Long J, Yang X, Wang D, Yang X, Zhao L, Hu K, Pan J, Sang X, Wang K, Zhao H. Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice. Ann Transl Med 2019;7:467. [PMID: 31700903 DOI: 10.21037/atm.2019.08.67] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
67 Van Dyke AL, Shiels MS, Jones GS, Pfeiffer RM, Petrick JL, Beebe-Dimmer JL, Koshiol J. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013. Cancer 2019;125:1489-98. [PMID: 30645774 DOI: 10.1002/cncr.31942] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
68 Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE. Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base. J Gastrointest Surg. 2015;19:1794-1801. [PMID: 26293376 DOI: 10.1007/s11605-015-2922-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
69 Bai Y, Liu ZS, Xiong JP, Xu WY, Lin JZ, Long JY, Miao F, Huang HC, Wan XS, Zhao HT. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol. 2018;24:5167-5178. [PMID: 30568393 DOI: 10.3748/wjg.v24.i45.5167] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
70 Moeini A, Haber PK, Sia D. Cell of origin in biliary tract cancers and clinical implications. JHEP Rep 2021;3:100226. [PMID: 33665585 DOI: 10.1016/j.jhepr.2021.100226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
71 Feng F, Cheng Q, Yang L, Zhang D, Ji S, Zhang Q, Lin Y, Li F, Xiong L, Liu C, Jiang X. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing. Oncotarget 2017;8:5349-60. [PMID: 28029662 DOI: 10.18632/oncotarget.14146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
72 Lee MH, Gao YT, Huang YH, McGee EE, Lam T, Wang B, Shen MC, Rashid A, Pfeiffer RM, Hsing AW, Koshiol J. A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer. Hepatology 2020;71:917-28. [PMID: 31318976 DOI: 10.1002/hep.30861] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
73 Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21:12211-12217. [PMID: 26604631 DOI: 10.3748/wjg.v21.i43.12211] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 66] [Article Influence: 17.2] [Reference Citation Analysis]
74 Maharaj R, Cave C, Sarran K, Bascombe N, Dan D, Greaves W, Warner WA. A case report of the clear cell variant of gallbladder carcinoma. Int J Surg Case Rep 2017;32:36-9. [PMID: 28222323 DOI: 10.1016/j.ijscr.2017.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
75 Roa I, de Toro G, Fernández F, Game A, Muñoz S, de Aretxabala X, Javle M. Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer. Diagn Pathol 2015;10:148. [PMID: 26294099 DOI: 10.1186/s13000-015-0381-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
76 Wang J, Xu C, Cheng Q, Zhao J, Wu S, Li W, Ma W, Liu C, Jiang X. RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma. Front Oncol 2020;10:823. [PMID: 32547950 DOI: 10.3389/fonc.2020.00823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 García P, Bizama C, Rosa L, Espinoza JA, Weber H, Cerda-Infante J, Sánchez M, Montecinos VP, Lorenzo-Bermejo J, Boekstegers F, Dávila-López M, Alfaro F, Leiva-Acevedo C, Parra Z, Romero D, Kato S, Leal P, Lagos M, Roa JC. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor. Biol Res 2020;53:13. [PMID: 32293552 DOI: 10.1186/s40659-020-00282-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
78 Jansen H, Pape UF, Utku N. A review of systemic therapy in biliary tract carcinoma. J Gastrointest Oncol 2020;11:770-89. [PMID: 32953160 DOI: 10.21037/jgo-20-203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
79 Irfan M, Delgado RZR, Frias-Lopez J. The Oral Microbiome and Cancer. Front Immunol 2020;11:591088. [PMID: 33193429 DOI: 10.3389/fimmu.2020.591088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
80 Steffen T, Ebinger SM, Tarantino I, Widmann B. Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis. J Gastrointest Surg 2020;24:633-42. [DOI: 10.1007/s11605-019-04175-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Al Manasra AR, Bani Hani M, Qandeel H, Al Asmar S, Alqudah M, Al-Zoubi N, Nadig S, Hamouri S, Obeidat K, Al-Muqaimi N. Trends of Gallbladder Cancer in Jordan Over 2 Decades: Where Are We? Clin Med Insights Case Rep 2018;11:1179547618771699. [PMID: 29760576 DOI: 10.1177/1179547618771699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
82 Ryu S, Chang Y, Yun KE, Jung HS, Shin JH, Shin H. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study. Am J Gastroenterol 2016;111:1476-87. [PMID: 27575712 DOI: 10.1038/ajg.2016.345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
83 Widmann B, Warschkow R, Beutner U, Weitzendorfer M, Ukegjini K, Schmied BM, Tarantino I, Steffen T. Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis. Langenbecks Arch Surg 2020;405:573-84. [PMID: 32458141 DOI: 10.1007/s00423-020-01878-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Wencong M, Jinghan W, Yong Y, Jianyang A, Bin L, Qingbao C, Chen L, Xiaoqing J. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway. Front Oncol 2020;10:545. [PMID: 32363163 DOI: 10.3389/fonc.2020.00545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Jia Y, Samadzadeh S, Cornford M, Ji P, French SW. Educational Case: Incidental Gallbladder Adenocarcinoma. Acad Pathol 2020;7:2374289520909504. [PMID: 32206701 DOI: 10.1177/2374289520909504] [Reference Citation Analysis]
86 Cai Q, Wang X, Wang S, Jin L, Ding J, Zhou D, Ma F. Gallbladder Cancer Progression Is Reversed by Nanomaterial-Induced Photothermal Therapy in Combination with Chemotherapy and Autophagy Inhibition. Int J Nanomedicine 2020;15:253-62. [PMID: 32021178 DOI: 10.2147/IJN.S231289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
87 You MS, Ryu JK, Choi YH, Choi JH, Huh G, Paik WH, Lee SH, Kim YT. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin. BMC Cancer 2019;19:10. [PMID: 30611225 DOI: 10.1186/s12885-018-5211-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
88 Diao H, Xu X, Zhao B, Yang G. miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer. Mol Med Rep 2021;24:528. [PMID: 34036386 DOI: 10.3892/mmr.2021.12167] [Reference Citation Analysis]
89 Wu Y, Meng D, You Y, Sun R, Fu M, Yan Q, Zhang S, Fang Z, Bao J, Li Y. Hypoxia Inducible Factor-1alpha (HIF-1A) plays different roles in Gallbladder Cancer and Normal Gallbladder Tissues. J Cancer 2021;12:827-39. [PMID: 33403040 DOI: 10.7150/jca.46749] [Reference Citation Analysis]
90 Gu Q, Zhou G, Xu T. Risk factors for gallstone disease in Shanghai: An observational study. Medicine (Baltimore) 2020;99:e18754. [PMID: 32011459 DOI: 10.1097/MD.0000000000018754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Torabi Sagvand B, Edwards K, Shen B. Frequency, Risk Factors, and Outcome of Gallbladder Polyps in Patients With Primary Sclerosing Cholangitis: A Case-Control Study. Hepatol Commun 2018;2:1440-5. [PMID: 30556033 DOI: 10.1002/hep4.1276] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
92 Fatemi SM, Doosti A, Shokri D, Ghorbani-Dalini S, Molazadeh M, Tavakoli H, Minakari M, Tavakkoli H. Is There a Correlation between Helicobacter Pylori and Enterohepatic Helicobacter Species and Gallstone Cholecystitis? Middle East J Dig Dis 2018;10:24-30. [PMID: 29682244 DOI: 10.15171/mejdd.2017.86] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Cruz J, Matos AP, Neta JO, Ramalho M. Carcinosarcoma of the gallbladder-an exceedingly rare tumour. BJR Case Rep 2016;2:20160019. [PMID: 30460034 DOI: 10.1259/bjrcr.20160019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
94 Kemp Bohan PM, Kirby DT, Chick RC, Bader JO, Clifton GT, Vreeland TJ, Nelson DW. Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients. Ann Surg Oncol 2021;28:1466-80. [PMID: 32749621 DOI: 10.1245/s10434-020-08973-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
95 Gupta A, Gupta S, Mani R, Durgapal P, Goyal B, Rajput D, Rao S, Dhar P, Gupta M, Kishore S, Kant R. Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma. J Carcinog 2021;20:7. [PMID: 34321957 DOI: 10.4103/jcar.JCar_4_21] [Reference Citation Analysis]
96 Erlangga Z, Wolff K, Poth T, Peltzer A, Nahnsen S, Spielberg S, Timrott K, Woller N, Kühnel F, Manns MP, Saborowski A, Vogel A, Saborowski M. Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer. Cancers (Basel) 2019;11:E1904. [PMID: 31795490 DOI: 10.3390/cancers11121904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
97 Gupta P, Bansal V, Kalra N, Samanta J, Mandavdhare H, Sharma V, Dutta U, Kochhar R, Sandhu MS. Should patients with unresectable gallbladder cancer with hilar involvement undergo unilateral or bilateral percutaneous biliary drainage in the setting of cholangitis? Clin Exp Hepatol 2021;7:7-12. [PMID: 34027110 DOI: 10.5114/ceh.2021.104674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
98 Oweira H, Mehrabi A, Giryes A, Tekbas A, Abdel-Rahman O. External validation of the 8th American Joint Committee on Cancer staging system for gall bladder carcinoma. J Gastrointest Oncol 2018;9:1084-90. [PMID: 30603127 DOI: 10.21037/jgo.2018.08.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
99 Cunha Júnior AD, Bragagnoli AC, Costa FO, Carvalheira JBC. Repurposing metformin for the treatment of gastrointestinal cancer. World J Gastroenterol 2021;27:1883-904. [PMID: 34007128 DOI: 10.3748/wjg.v27.i17.1883] [Reference Citation Analysis]
100 Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, Hao J, Liu L, Liu F, Hu Y, Jiang L, Ma Q, Lu W, Liu Y. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway. Int J Biol Sci 2020;16:739-51. [PMID: 32071545 DOI: 10.7150/ijbs.40516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
101 Chen M, Li S, Topatana W, Lv X, Cao J, Hu J, Lin J, Juengpanich S, Shen J, Cai X. Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery. Front Oncol 2020;10:537789. [PMID: 33505902 DOI: 10.3389/fonc.2020.537789] [Reference Citation Analysis]
102 Bastiaenen VP, Tuijp JE, van Dieren S, Besselink MG, van Gulik TM, Koens L, Tanis PJ, Bemelman WA. Safe, selective histopathological examination of gallbladder specimens: a systematic review. Br J Surg 2020;107:1414-28. [PMID: 32639049 DOI: 10.1002/bjs.11759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Zhu S, Yang J, Cui X, Zhao Y, Tao Z, Xia F, Chen L, Huang J, Ma X. Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci Rep 2019;9:1823. [PMID: 30755649 DOI: 10.1038/s41598-018-38396-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
104 Chen C, Wang L, Zhang R, Li Q, Zhao YL, Zhang GJ, Li WZ, Geng ZM. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer. Chronic Dis Transl Med 2019;5:188-96. [PMID: 31891130 DOI: 10.1016/j.cdtm.2019.08.004] [Reference Citation Analysis]
105 Liu Z, Jin H, Yang S, Cao H, Zhang Z, Wen B, Zhou S. SDC1 knockdown induces epithelial-mesenchymal transition and invasion of gallbladder cancer cells via the ERK/Snail pathway. J Int Med Res 2020;48:300060520947883. [PMID: 32812461 DOI: 10.1177/0300060520947883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Lin R, Zhan M, Yang L, Wang H, Shen H, Huang S, Huang X, Xu S, Zhang Z, Li W, Liu Q, Shi Y, Chen W, Yu J, Wang J. Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation. Oncogene 2020;39:4983-5000. [PMID: 32514152 DOI: 10.1038/s41388-020-1349-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
107 Zhu Z, Zhu Q, Cai D, Chen L, Xie W, Bai Y, Luo K. Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome. Oncol Rep 2021;45:113. [PMID: 33907835 DOI: 10.3892/or.2021.8064] [Reference Citation Analysis]
108 Gamboa AC, Maithel SK. The Landmark Series: Gallbladder Cancer. Ann Surg Oncol 2020;27:2846-58. [PMID: 32474816 DOI: 10.1245/s10434-020-08654-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
109 Cai Q, Wang S, Jin L, Weng M, Zhou D, Wang J, Tang Z, Quan Z. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer. 2019;18:82. [PMID: 30953511 DOI: 10.1186/s12943-019-1016-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 25.0] [Reference Citation Analysis]
110 Yang G, Yin B. Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma. Sci Rep 2017;7:5982. [PMID: 28729631 DOI: 10.1038/s41598-017-06234-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
111 Sung YN, Kim SJ, Jun SY, Yoo C, Kim KP, Lee JH, Hwang DW, Hwang S, Lee SS, Hong SM. Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma. Front Oncol 2021;11:658564. [PMID: 34367955 DOI: 10.3389/fonc.2021.658564] [Reference Citation Analysis]
112 Xu G, Wei X, Tu Q, Zhou C. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC. Biosci Rep 2020;40:BSR20190108. [PMID: 31799620 DOI: 10.1042/BSR20190108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Zuo M, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget 2016;7:35302-12. [PMID: 27167107 DOI: 10.18632/oncotarget.9181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
114 Ng YA, Tan QT, Wan WK, Goh YC. A case report of wound site seeding following cholecystectomy for dysplastic gallbladder. Int J Surg Case Rep 2017;35:87-93. [PMID: 28502483 DOI: 10.1016/j.ijscr.2017.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Yang G, Zhang L, Li R, Wang L. The role of microRNAs in gallbladder cancer. Mol Clin Oncol. 2016;5:7-13. [PMID: 27330755 DOI: 10.3892/mco.2016.905] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
116 Lin J, Cao Y, Yang X, Li G, Shi Y, Wang D, Long J, Song Y, Mao J, Xie F, Bai Y, Zhang L, Yang X, Wan X, Wang A, Guan M, Zhao L, Hu K, Pan J, Huo L, Lu X, Mao Y, Sang X, Zhang H, Wang K, Wang X, Zhao H. Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021;11:4585-98. [PMID: 33754015 DOI: 10.7150/thno.56539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Rahman R, Simoes EJ, Schmaltz C, Jackson CS, Ibdah JA. Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med. 2017;6:874-880. [PMID: 28317286 DOI: 10.1002/cam4.1044] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
118 Xu S, Zhan M, Wang J. Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks. Cell Death Discov 2017;3:17069. [PMID: 29188076 DOI: 10.1038/cddiscovery.2017.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
119 Hamad A, Cloyd JM, Dillhoff M, Manilchuk A, Pawlik TM, Tsung A, Ejaz A. Comparison of lymph node evaluation and yield among patients undergoing open and minimally invasive surgery for gallbladder adenocarcinoma. Surg Endosc 2021;35:2223-8. [PMID: 32430521 DOI: 10.1007/s00464-020-07635-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
120 Chandra V, Kim JJ, Mittal B, Rai R. MicroRNA aberrations: An emerging field for gallbladder cancer management. World J Gastroenterol 2016;22:1787-99. [PMID: 26855538 DOI: 10.3748/wjg.v22.i5.1787] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
121 Prasai K, Tella SH, Yadav S, Kommalapati A, Mara K, Mady M, Hassan MA, Wongjarupong N, Rodriguez-Payan N, Borad M, Patel T, Roberts LR, Mahipal A. Aspirin and Statin Use and the Risk of Gallbladder Cancer. Cancers (Basel) 2021;13:1186. [PMID: 33803387 DOI: 10.3390/cancers13051186] [Reference Citation Analysis]
122 Lundgren L, Muszynska C, Ros A, Persson G, Gimm O, Valter L, Andersson B, Sandström P. Are Incidental Gallbladder Cancers Missed with a Selective Approach of Gallbladder Histology at Cholecystectomy? World J Surg 2018;42:1092-9. [PMID: 28900706 DOI: 10.1007/s00268-017-4215-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
123 Baichan P, Naicker P, Devar JWS, Smith M, Candy GP, Nweke E. Targeting gallbladder cancer: a pathway based perspective. Mol Biol Rep 2020;47:2361-9. [PMID: 32020429 DOI: 10.1007/s11033-020-05269-x] [Reference Citation Analysis]
124 Albrecht T, Brinkmann F, Albrecht M, Lonsdorf AS, Mehrabi A, Hoffmann K, Kulu Y, Charbel A, Vogel MN, Rupp C, Köhler B, Springfeld C, Schirmacher P, Roessler S, Goeppert B. Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer. Cancers (Basel) 2021;13:1682. [PMID: 33918309 DOI: 10.3390/cancers13071682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Zhu X, Li T, Niu X, Chen L, Ge C. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer. Oncol Lett 2020;20:44. [PMID: 32802166 DOI: 10.3892/ol.2020.11903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Ayabe RI, Wach MM, Ruff SM, Diggs LP, Martin SP, Wiemken T, Hinyard L, Davis JL, Luu C, Hernandez JM. Gallbladder squamous cell carcinoma: An analysis of 1084 cases from the National Cancer Database. J Surg Oncol 2020. [PMID: 32510655 DOI: 10.1002/jso.26066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Dwivedi AN, Jain S, Dixit R. Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3:231-244. [PMID: 25789296 DOI: 10.12998/wjcc.v3.i3.231] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
128 Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer. Int J Mol Sci 2017;18:E1887. [PMID: 28858232 DOI: 10.3390/ijms18091887] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
129 Alshari OM, Dawaymeh TA, Tashtush NA, Aleshawi AJ, Al Manasra ARA, Obeidat KA. Completely resolved advanced biliary tract cancer after treatment by pembrolizumab: a report of two cases. Onco Targets Ther 2019;12:5293-8. [PMID: 31308699 DOI: 10.2147/OTT.S197559] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
130 Rojas-Sepúlveda D, Tittarelli A, Gleisner MA, Ávalos I, Pereda C, Gallegos I, González FE, López MN, Butte JM, Roa JC, Fluxá P, Salazar-Onfray F. Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer. Cancer Immunol Immunother 2018;67:1897-910. [PMID: 29600445 DOI: 10.1007/s00262-018-2157-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
131 Ye J, Qi L, Du Z, Yu L, Chen K, Li R, Feng R, Zhai W. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer. Aging (Albany NY) 2021;13:5607-20. [PMID: 33591948 DOI: 10.18632/aging.202488] [Reference Citation Analysis]
132 Lau CSM, Zywot A, Mahendraraj K, Chamberlain RS. Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973-2013). HPB Surg. 2017;2017:1532835. [PMID: 28638176 DOI: 10.1155/2017/1532835] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
133 Feng X, Cao JS, Chen MY, Zhang B, Juengpanich S, Hu JH, Topatana W, Li SJ, Shen JL, Xiao GY, Cai XJ, Yu H. Laparoscopic surgery for early gallbladder carcinoma: A systematic review and meta-analysis. World J Clin Cases 2020;8:1074-86. [PMID: 32258078 DOI: 10.12998/wjcc.v8.i6.1074] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Wang P, Shi Q, Zuo T, He X, Yu J, Wang W. Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levels. Oncol Lett 2016;11:2061-6. [PMID: 26998122 DOI: 10.3892/ol.2016.4191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
135 Ren T, Li YS, Dang XY, Li Y, Shao ZY, Bao RF, Shu YJ, Wang XA, Wu WG, Wu XS, Li ML, Cao H, Wang KH, Cai HY, Jin C, Jin HH, Yang B, Jiang XQ, Gu JF, Cui YF, Zhang ZY, Zhu CF, Sun B, Dai CL, Zheng LH, Cao JY, Fei ZW, Liu CJ, Li B, Liu J, Qian YB, Wang Y, Hua YW, Zhang X, Liu C, Lau WY, Liu YB. Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in China. World J Gastrointest Surg 2021;13:176-86. [PMID: 33643537 DOI: 10.4240/wjgs.v13.i2.176] [Reference Citation Analysis]
136 Ma F, Zhang M, Gong W, Weng M, Quan Z. MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma. PLoS One. 2015;10:e0126499. [PMID: 25962180 DOI: 10.1371/journal.pone.0126499] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
137 He Y, Xue C, Yu Y, Chen J, Chen X, Ren F, Ren Z, Cui G, Sun R. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res 2018;10:3857-65. [PMID: 30288117 DOI: 10.2147/CMAR.S175681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
138 Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY. The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma. Onco Targets Ther 2016;9:3633-42. [PMID: 27382301 DOI: 10.2147/OTT.S101310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
139 Higuchi R, Yazawa T, Uemura S, Matsunaga Y, Ota T, Araida T, Furukawa T, Yamamoto M. Examination of Prognostic Factors Affecting Long-Term Survival of Patients with Stage 3/4 Gallbladder Cancer without Distant Metastasis. Cancers (Basel) 2020;12:E2073. [PMID: 32726993 DOI: 10.3390/cancers12082073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
140 Xu WY, Zhang HH, Yang XB, Bai Y, Lin JZ, Long JY, Xiong JP, Zhang JW, Sang XT, Zhao HT. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients. World J Gastroenterol. 2018;24:1451-1463. [PMID: 29632426 DOI: 10.3748/wjg.v24.i13.1451] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
141 Lin J, Peng X, Dong K, Long J, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H, Liang H. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun 2021;12:4753. [PMID: 34362903 DOI: 10.1038/s41467-021-25012-9] [Reference Citation Analysis]
142 Sun L, Wang D, Zhang M, Jin Y, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience. Cancer Manag Res 2020;12:12137-50. [PMID: 33269006 DOI: 10.2147/CMAR.S271044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Deng M, Qin Y, Chen X, Li D, Wang Q, Zheng H, Gu L, Deng C, Xue Y, Zhu D, Wang Q, Wang J. Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation. Oncol Lett. 2017;13:3850-3858. [PMID: 28521485 DOI: 10.3892/ol.2017.5914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
144 Xu W, Wu X, Wang X, Yu S, Xu G, Xiong J, Zhang J, Sang X, Zheng Y, Liu W. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma. Cancer Manag Res 2020;12:3271-83. [PMID: 32494191 DOI: 10.2147/CMAR.S243326] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Lu W, Hu Y, Ma Q, Zhou L, Jiang L, Li Z, Zhao S, Xu Y, Shi W, Li S, Liu Y. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Oncotarget 2016;7:62364-76. [PMID: 27577078 DOI: 10.18632/oncotarget.11634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
146 Kai K, Tanaka T, Ide T, Kawaguchi A, Noshiro H, Aishima S. Immunohistochemical analysis of the aggregation of CD1a-positive dendritic cells in resected specimens and its association with surgical outcomes for patients with gallbladder cancer. Transl Oncol 2021;14:100923. [PMID: 33129106 DOI: 10.1016/j.tranon.2020.100923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
147 Matsumoto Y, Fujimoto K, Mitsuoka E, Senda E, Shio S, Ichikawa K, Yamada H. Cholecystoduodenal fistula caused by aggressive mucinous gallbladder carcinoma with a porcelain gallbladder. Clin J Gastroenterol 2019;12:460-5. [PMID: 30919282 DOI: 10.1007/s12328-019-00969-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Geng Z, Cai Z, Zhang Z, Tang Z, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li W, Wang L, Si S. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma. WJG 2019;25:5655-66. [DOI: 10.3748/wjg.v25.i37.5655] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
149 Tang H, Shi X, Zhu P, Guo W, Li J, Yan B, Zhang S. Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition. Oncol Lett 2021;22:609. [PMID: 34188711 DOI: 10.3892/ol.2021.12870] [Reference Citation Analysis]
150 Ouyang B, Pan N, Zhang H, Xing C, Ji W. miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway. Oncol Rep 2021;45:15. [PMID: 33649824 DOI: 10.3892/or.2021.7966] [Reference Citation Analysis]
151 Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infect Agent Cancer. 2016;11:12. [PMID: 26941832 DOI: 10.1186/s13027-016-0057-x57] [Reference Citation Analysis]
152 Wi Y, Woo H, Won YJ, Jang JY, Shin A. Trends in Gallbladder Cancer Incidence and Survival in Korea. Cancer Res Treat 2018;50:1444-51. [PMID: 29370591 DOI: 10.4143/crt.2017.279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
153 Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infect Agent Cancer 2016;11:12. [PMID: 26941832 DOI: 10.1186/s13027-016-0057-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
154 Yoo J, Lee JM, Yoon JH, Joo I, Lee DH. Additional Value of Integrated 18F-FDG PET/MRI for Evaluating Biliary Tract Cancer: Comparison with Contrast-Enhanced CT. Korean J Radiol 2021;22:714-24. [PMID: 33660461 DOI: 10.3348/kjr.2020.0689] [Reference Citation Analysis]
155 Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L. LINC00152: A pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif 2017;50. [PMID: 28464433 DOI: 10.1111/cpr.12349] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
156 Rai R, Kim JJ, Misra S, Kumar A, Mittal B. A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations. Int J Mol Sci. 2015;16:28038-28049. [PMID: 26602921 DOI: 10.3390/ijms161226077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
157 Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder Cancer in the 21st Century. J Oncol. 2015;2015:967472. [PMID: 26421012 DOI: 10.1155/2015/967472] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 17.7] [Reference Citation Analysis]
158 Kim TG. Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy. Radiat Oncol J 2017;35:359-67. [PMID: 29249117 DOI: 10.3857/roj.2017.00388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
159 Kocaöz S, Turan G. Preneoplastic and neoplastic gallbladder lesions detected after cholecystectomy. Prz Gastroenterol 2019;14:193-7. [PMID: 31649791 DOI: 10.5114/pg.2019.82675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
160 Pandey A, Stawiski EW, Durinck S, Gowda H, Goldstein LD, Barbhuiya MA, Schröder MS, Sreenivasamurthy SK, Kim SW, Phalke S, Suryamohan K, Lee K, Chakraborty P, Kode V, Shi X, Chatterjee A, Datta K, Khan AA, Subbannayya T, Wang J, Chaudhuri S, Gupta S, Shrivastav BR, Jaiswal BS, Poojary SS, Bhunia S, Garcia P, Bizama C, Rosa L, Kwon W, Kim H, Han Y, Yadav TD, Ramprasad VL, Chaudhuri A, Modrusan Z, Roa JC, Tiwari PK, Jang JY, Seshagiri S. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. Nat Commun 2020;11:4225. [PMID: 32839463 DOI: 10.1038/s41467-020-17880-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
161 Li M, Chen L, Qu Y, Sui F, Yang Q, Ji M, Shi B, Chen M, Hou P. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. Oncotarget 2017;8:36319-30. [PMID: 28422736 DOI: 10.18632/oncotarget.16751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
162 Gao Y, Wang Z, Zhu Y, Zhu Q, Yang Y, Jin Y, Zhang F, Jiang L, Ye Y, Li H, Zhang Y, Liang H, Xiang S, Miao H, Liu Y, Hao Y. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma. Cancer Sci 2019;110:3510-9. [PMID: 31487418 DOI: 10.1111/cas.14190] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
163 Lu W, Zhang Y, Zhou L, Wang X, Mu J, Jiang L, Hu Y, Dong P, Liu Y. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. Tumour Biol. 2015;. [PMID: 26546436 DOI: 10.1007/s13277-015-4308-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
164 Gao J, Dai C, Yu X, Yin XB, Liao WJ, Huang Y, Zhou F. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1. Gene Ther 2021;28:306-18. [PMID: 32917950 DOI: 10.1038/s41434-020-00187-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
165 Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci 2016;17:E791. [PMID: 27223281 DOI: 10.3390/ijms17050791] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
166 Bains L, Maranna H, Lal P, Kori R, Kaur D, Mallya V, Singh V. The giant resectable carcinoma of gall bladder-a case report. BMC Surg 2021;21:133. [PMID: 33726732 DOI: 10.1186/s12893-021-01117-2] [Reference Citation Analysis]
167 Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC. Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. HPB (Oxford) 2015;17:1119-23. [PMID: 26374242 DOI: 10.1111/hpb.12504] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
168 Wang J, Zhang ZG, Zhang WG. A modified surgical approach of hepatopancreatoduodenectomy for advanced gallbladder cancer: Report of two cases and literature review. J Huazhong Univ Sci Technolog Med Sci 2017;37:855-60. [PMID: 29270743 DOI: 10.1007/s11596-017-1817-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Hryciuk B, Pęksa R, Bieńkowski M, Szymanowski B, Radecka B, Winnik K, Żok J, Cichowska N, Iliszko M, Duchnowska R. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Sci Rep 2020;10:1871. [PMID: 32024900 DOI: 10.1038/s41598-020-58777-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Fernandez Y Viesca M, Arvanitakis M. Early Diagnosis And Management Of Malignant Distal Biliary Obstruction: A Review On Current Recommendations And Guidelines. Clin Exp Gastroenterol. 2019;12:415-432. [PMID: 31807048 DOI: 10.2147/ceg.s195714] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
171 Zhang X, Kong Z, Xu X, Yun X, Chao J, Ding D, Li T, Gao Y, Guan N, Zhu C, Qin X. ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation. J Cancer 2021;12:1926-35. [PMID: 33753990 DOI: 10.7150/jca.53325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Wang FT, Li XP, Pan MS, Hassan M, Sun W, Fan YZ. Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer-associated fibroblasts. Cancer Med 2021;10:6035-47. [PMID: 34331381 DOI: 10.1002/cam4.4150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Bo X, Wang J, Wang C, Nan L, Gao Z, Xin Y, Li M, Shen S, Liu H, Ni X, Suo T, Zhang D, Lu P, Wang Y, Liu H. High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer. Cancer Sci 2020;111:817-25. [PMID: 31925976 DOI: 10.1111/cas.14302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Shen H, Zhan M, Zhang Y, Huang S, Xu S, Huang X, He M, Yao Y, Man M, Wang J. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Cell Death Dis 2018;9:71. [PMID: 29358655 DOI: 10.1038/s41419-017-0107-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
175 Sahoo B Sr, Barik S, Mishra P, Das Majumdar SK, Parida DK. Metastasis to Breast From Carcinoma Gallbladder: A Case Report and Review of Literature. Cureus 2020;12:e11307. [PMID: 33282584 DOI: 10.7759/cureus.11307] [Reference Citation Analysis]
176 Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, Huang S, Huang X, Lin R, Shi Y, Liu Q, Chen W, Mohan M, Wang J. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun 2019;10:5492. [PMID: 31792210 DOI: 10.1038/s41467-019-13420-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
177 Pang Q, Zhang LQ, Wang RT, Bi JB, Zhang JY, Qu K, Liu SS, Song SD, Xu XS, Wang ZX. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol. 2015;21:6675-6683. [PMID: 26074706 DOI: 10.3748/wjg.v21.i21.6675] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
178 Zhao X, Xu M, Cai Z, Yuan W, Cui W, Li MD. Identification of LIFR, PIK3R1, and MMP12 as Novel Prognostic Signatures in Gallbladder Cancer Using Network-Based Module Analysis. Front Oncol 2019;9:325. [PMID: 31119098 DOI: 10.3389/fonc.2019.00325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
179 Shen H, He M, Lin R, Zhan M, Xu S, Huang X, Xu C, Chen W, Yao Y, Mohan M, Wang J. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. J Exp Clin Cancer Res 2019;38:247. [PMID: 31182136 DOI: 10.1186/s13046-019-1250-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
180 Zheng X, Gao L, Wang BT, Shen P, Yuan XF, Zhang LQ, Yang L, Zhang DP, Zhang Q, Wang XM. Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer. Histol Histopathol 2020;35:579-87. [PMID: 31745968 DOI: 10.14670/HH-18-186] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
181 Zha L, Garrett S, Sun J. Salmonella Infection in Chronic Inflammation and Gastrointestinal Cancer. Diseases 2019;7:E28. [PMID: 30857369 DOI: 10.3390/diseases7010028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
182 Kabbach G, Assi HA, Bolotin G, Schuster M, Lee HJ, Tadros M. Hepatobiliary Tumors: Update on Diagnosis and Management. J Clin Transl Hepatol 2015;3:169-81. [PMID: 26623263 DOI: 10.14218/JCTH.2015.00012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
183 Ying H, Fengying S, Feng H, Yanhong W, Xianru X, Xiaolei T. Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme. Transl Oncol 2021;14:100928. [PMID: 33212417 DOI: 10.1016/j.tranon.2020.100928] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Odutola MK, Olukomogbon T, Igbinoba F, Otu TI, Ezeome E, Hassan R, Jedy-Agba E, Adebamowo SN. Cancers Attributable to Overweight and Obesity From 2012 to 2014 in Nigeria: A Population-Based Cancer Registry Study. Front Oncol 2019;9:460. [PMID: 31245287 DOI: 10.3389/fonc.2019.00460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
185 Tsuchiya Y, Mishra K, Kapoor VK, Vishwakarma R, Behari A, Ikoma T, Asai T, Endoh K, Nakamura K. Plasma Helicobacter pylori Antibody Titers and Helicobacter pylori Infection Positivity Rates in Patients with Gallbladder Cancer or Cholelithiasis: a Hospital-Based Case-Control Study. Asian Pac J Cancer Prev. 2018;19:1911-1915. [PMID: 30051672 DOI: 10.22034/apjcp.2018.19.7.1911] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
186 Scherer D, Dávila López MD, Goeppert B, Abrahamsson S, González Silos RG, Nova I, Marcelain K, Roa JC, Ibberson D, Umu SU, Rounge TB, Roessler S, Bermejo JL. RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic Profiling. Cancers (Basel) 2020;12:E2510. [PMID: 32899426 DOI: 10.3390/cancers12092510] [Reference Citation Analysis]
187 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
188 Sulieman I, Elmoghazy W, El Ansari W, Elaffandi A, Khalaf H. Gallbladder cancer: 7-Year experience from Qatar. Ann Med Surg (Lond) 2019;44:33-8. [PMID: 31304011 DOI: 10.1016/j.amsu.2019.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Cherif S, Rais H, Hakmaoui A, Sellami S, Elantri S, Amine A. Linking Helicobacter pylori with gallbladder and biliary tract cancer in Moroccan population using clinical and pathological profiles. Bioinformation 2019;15:735-43. [PMID: 31831956 DOI: 10.6026/97320630015735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
190 Hendaoui I, Lahmar A, Campo L, Mebarki S, Bichet S, Hess D, Degen M, Kchir N, Charrada-Ben Farhat L, Hefaiedh R, Ruiz C, Terracciano LM, Tucker RP, Hendaoui L, Chiquet-Ehrismann R. Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers. Front Immunol 2020;11:630139. [PMID: 33692777 DOI: 10.3389/fimmu.2020.630139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 de Savornin Lohman E, de Bitter T, Verhoeven R, van der Geest L, Hagendoorn J, Haj Mohammad N, Daams F, Klümpen HJ, van Gulik T, Erdmann J, de Boer M, Hoogwater F, Koerkamp BG, Braat A, Verheij J, Nagtegaal I, van Laarhoven C, van den Boezem P, van der Post R, de Reuver P. Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort. Cancers (Basel) 2020;12:E918. [PMID: 32283627 DOI: 10.3390/cancers12040918] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
192 Nemunaitis JM, Brown-Glabeman U, Soares H, Belmonte J, Liem B, Nir I, Phuoc V, Gullapalli RR. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer 2018;18:665. [PMID: 29914418 DOI: 10.1186/s12885-018-4575-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
193 Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 2017;23:3978-3998. [PMID: 28652652 DOI: 10.3748/wjg.v23.i22.3978] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 93] [Article Influence: 37.3] [Reference Citation Analysis]
194 Kanetkar AV, Patkar S, Khobragade KH, Ostwal V, Ramaswamy A, Goel M. Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases. J Gastrointest Cancer 2019;50:298-303. [PMID: 29435905 DOI: 10.1007/s12029-018-0070-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
195 Zhang L, Wang R, Chen W, Xu X, Dong S, Fan H, Liu C. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. HPB (Oxford). 2016;18:600-607. [PMID: 27346141 DOI: 10.1016/j.hpb.2016.03.608] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
196 de Savornin Lohman EAJ, van der Geest LG, de Bitter TJJ, Nagtegaal ID, van Laarhoven CJHM, van den Boezem P, van der Post CS, de Reuver PR. Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease. Ann Surg Oncol 2020;27:1132-42. [PMID: 31741109 DOI: 10.1245/s10434-019-08074-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
197 Zheng H, Wang JJ, Zhao LJ, Yang XR, Yu YL. Exosomal miR-182 regulates the effect of RECK on gallbladder cancer. World J Gastroenterol 2020;26:933-46. [PMID: 32206004 DOI: 10.3748/wjg.v26.i9.933] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
198 Su W, Jiang X, Chen M, Huang M, Tang N, Wang X, Li X, She F, Chen Y. cIAP1 promotes proliferation and migration and prevents apoptosis in gallbladder cancer in vitro. Biosci Rep 2019;39:BSR20182266. [PMID: 30902881 DOI: 10.1042/BSR20182266] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 2020;145:102854. [PMID: 31877535 DOI: 10.1016/j.critrevonc.2019.102854] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 41.5] [Reference Citation Analysis]
200 Zhang ZG, Chen Y, Ji R, Zhao YJ, Wang J, Robinson L, Chen XP, Zhang L. Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review. BMC Cancer. 2018;18:1046. [PMID: 30373546 DOI: 10.1186/s12885-018-4969-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
201 Aldossary MY, Alayed AA, Amr SS, Alqahtani S, Alnahawi M, Alqahtani MS. Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study. Ann Med Surg (Lond) 2018;35:117-23. [PMID: 30294442 DOI: 10.1016/j.amsu.2018.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
202 Barra J, Cerda-Infante J, Sandoval L, Gajardo-Meneses P, Henriquez JF, Labarca M, Metz C, Venegas J, Retamal C, Oyanadel C, Cancino J, Soza A, Cuello MA, Roa JC, Montecinos VP, Gonzalez A. D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy. Cancers (Basel) 2021;13:3622. [PMID: 34298835 DOI: 10.3390/cancers13143622] [Reference Citation Analysis]
203 Zhou Z, Peng Y, Wu X, Meng S, Yu W, Zhao J, Zhang H, Wang J, Li W. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer. Cell Oncol (Dordr) 2019;42:81-92. [PMID: 30276551 DOI: 10.1007/s13402-018-0410-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
204 Huang S, Wang H, Chen W, Zhan M, Xu S, Huang X, Lin R, Shen H, Wang J. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer. J Cell Mol Med 2020;24:1599-613. [PMID: 31782270 DOI: 10.1111/jcmm.14851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
205 Zhang D, Wang Y, Dai Y, Wang J, Suo T, Pan H, Liu H, Shen S, Liu H. CIZ1 promoted the growth and migration of gallbladder cancer cells. Tumour Biol 2015;36:2583-91. [PMID: 25427641 DOI: 10.1007/s13277-014-2876-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
206 Dubé-Delarosbil C, St-Pierre Y. The emerging role of galectins in high-fatality cancers. Cell Mol Life Sci 2018;75:1215-26. [PMID: 29119229 DOI: 10.1007/s00018-017-2708-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
207 Lin JY, Bai DS, Zhou BH, Chen P, Qian JJ, Jin SJ, Jiang GQ. Positive relationship between number of negative lymph nodes and duration of gallbladder cancer cause-specific survival after surgery. Cancer Manag Res 2018;10:6961-9. [PMID: 30588101 DOI: 10.2147/CMAR.S187857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Jin YP, Hu YP, Wu XS, Wu YS, Ye YY, Li HF, Liu YC, Jiang L, Liu FT, Zhang YJ, Hao YJ, Liu XY, Liu YB. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma. Cell Death Dis. 2018;9:182. [PMID: 29416013 DOI: 10.1038/s41419-017-0258-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
209 Goetze TO, Bechstein WO, Bankstahl US, Keck T, Königsrainer A, Lang SA, Pauligk C, Piso P, Vogel A, Al-Batran SE. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial. BMC Cancer 2020;20:122. [PMID: 32059704 DOI: 10.1186/s12885-020-6610-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
210 Gupta A, Gupta S, Siddeek RAT, Chennatt JJ, Singla T, Rajput D, Kumar N, Sehrawat A, Kishore S, Gupta M. Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt. J Carcinog 2021;20:6. [PMID: 34321956 DOI: 10.4103/jcar.JCar_3_21] [Reference Citation Analysis]
211 Xu B, Chen Z, Zhang J, Chang J, Zhao W, Dong Z, Zhi X, Li T. Prognostic Value of Peripheral Whole Blood Cell Counts Derived Indexes in Gallbladder Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:707742. [PMID: 34262875 DOI: 10.3389/fonc.2021.707742] [Reference Citation Analysis]
212 Sun L, Ke X, Wang D, Yin H, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival. J Cancer 2021;12:4172-82. [PMID: 34093818 DOI: 10.7150/jca.49242] [Reference Citation Analysis]
213 Zhao X, Zheng H, Shan S, Wang K, Zhang M, Xie S, Liu C. Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study. Lipids Health Dis 2020;19:146. [PMID: 32576257 DOI: 10.1186/s12944-020-01322-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
214 Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther 2020;5:230. [PMID: 33028805 DOI: 10.1038/s41392-020-00324-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
215 Taramasco C, Figueroa K, Lazo Y, Demongeot J. Estimation of life expectancy of patients diagnosed with the most common cancers in the Valparaiso Region, Chile. Ecancermedicalscience 2017;11:713. [PMID: 28144287 DOI: 10.3332/ecancer.2017.713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Costa J, Lima N, Santos C. An overview on possible links between aflatoxin B1 exposure and gallbladder cancer. Mycotoxin Res 2021;37:205-14. [PMID: 34019215 DOI: 10.1007/s12550-021-00431-1] [Reference Citation Analysis]
217 Sachan A, Saluja SS, Nekarakanti PK, Nimisha, Mahajan B, Nag HH, Mishra PK. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer. 2020;20:826. [PMID: 32867709 DOI: 10.1186/s12885-020-07334-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
218 Wu Y, Meng D, You Y, Sun R, Yan Q, Bao J, Sun Y, Yun D, Li Y, Sun D. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma. Oncol Rep 2020;44:55-68. [PMID: 32627033 DOI: 10.3892/or.2020.7594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ghidini M, Pizzo C, Botticelli A, Hahne JC, Passalacqua R, Tomasello G, Petrelli F. Biliary tract cancer: current challenges and future prospects. Cancer Manag Res. 2019;11:379-388. [PMID: 30643463 DOI: 10.2147/cmar.s157156] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
220 Oneda E, Abu Hilal M, Zaniboni A. Biliary Tract Cancer: Current Medical Treatment Strategies.Cancers (Basel). 2020;12. [PMID: 32423017 DOI: 10.3390/cancers12051237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
221 Shah UA, Nandikolla AG, Rajdev L. Immunotherapeutic Approaches to Biliary Cancer. Curr Treat Options Oncol 2017;18:44. [PMID: 28660602 DOI: 10.1007/s11864-017-0486-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
222 García P, Lamarca A, Díaz J, Carrera E, Roa JC, On Behalf Of The European-Latin American Escalon Consortium. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers (Basel) 2020;12:E3670. [PMID: 33297469 DOI: 10.3390/cancers12123670] [Reference Citation Analysis]
223 Rakić M, Patrlj L, Kopljar M, Kliček R, Kolovrat M, Loncar B, Busic Z. Gallbladder cancer. Hepatobiliary Surg Nutr 2014;3:221-6. [PMID: 25392833 DOI: 10.3978/j.issn.2304-3881.2014.09.03] [Cited by in F6Publishing: 58] [Reference Citation Analysis]
224 Choi SJ, Kim Y, Jeon J, Gwak HJ, Kim M, Kang K, Kim Y, Jeong J, Jung YK, Lee KG, Choi HS, Jung DH, Lee SG, Lee Y, Shin SJ, Jang K, Rho M, Choi D. Association of Microbial Dysbiosis with Gallbladder Diseases Identified by Bile Microbiome Profiling. J Korean Med Sci 2021;36:e189. [PMID: 34282606 DOI: 10.3346/jkms.2021.36.e189] [Reference Citation Analysis]
225 Wang RT, Zhang LQ, Mu YP, Li JB, Xu XS, Pang Q, Sun LK, Zhang X, Dong SB, Wang L, Liu C. Prognostic significance of preoperative platelet count in patients with gallbladder cancer. World J Gastroenterol. 2015;21:5303-5310. [PMID: 25954104 DOI: 10.3748/wjg.v21.i17.5303] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
226 Ha GW, Lee MR, Kim JH. Cholecystocolic fistula caused by gallbladder carcinoma: preoperatively misdiagnosed as hepatic colon carcinoma. World J Gastroenterol 2015;21:4765-9. [PMID: 25914489 DOI: 10.3748/wjg.v21.i15.4765] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
227 Dixit R, Singh G, Pandey M, Basu S, Bhartiya SK, Singh KK, Shukla VK. Association of Methylenetetrahydrafolate Reductase Gene Polymorphism (MTHFR) in Patients with Gallbladder Cancer. J Gastrointest Cancer 2016;47:55-60. [PMID: 26687138 DOI: 10.1007/s12029-015-9794-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Qin Y, Meng L, Fu Y, Quan Z, Ma M, Weng M, Zhang Z, Gao C, Shi X, Han K. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Oncotarget 2017;8:19980-96. [PMID: 28212545 DOI: 10.18632/oncotarget.15301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
229 Zhang L, Miao R, Zhang X, Chen W, Zhou Y, Wang R, Zhang R, Pang Q, Xu X, Liu C. Exploring the diagnosis markers for gallbladder cancer based on clinical data. Front Med. 2015;9:350-355. [PMID: 26177708 DOI: 10.1007/s11684-015-0402-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
230 Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol 2019;5:93-102. [PMID: 31501784 DOI: 10.5114/ceh.2019.85166] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 19.0] [Reference Citation Analysis]
231 Tsuchiya Y, Loza E, Villa-Gomez G, Trujillo CC, Baez S, Asai T, Ikoma T, Endoh K, Nakamura K. Metagenomics of Microbial Communities in Gallbladder Bile from Patients with Gallbladder Cancer or Cholelithiasis. Asian Pac J Cancer Prev 2018;19:961-7. [PMID: 29693356 DOI: 10.22034/APJCP.2018.19.4.961] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
232 Tong C, Wang Y, Li J, Cen W, Zhang W, Zhu Z, Yu J, Lu B. Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway. Sci Rep 2021;11:4391. [PMID: 33623100 DOI: 10.1038/s41598-021-83924-4] [Reference Citation Analysis]
233 Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, Silos RG, Sticht C, Gretz N, Mehrabi A, Bewerunge-Hudler M, Pusch S, Bermejo JL, Dietrich P, Schirmacher P, Renner M, Roessler S. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. Sci Rep 2019;9:4796. [PMID: 30886199 DOI: 10.1038/s41598-019-40857-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
234 Matsuyama R, Matsuo K, Mori R, Sugita M, Yamaguchi N, Kubota T, Kameda K, Mochizuki Y, Takagawa R, Kadokura T, Matsuda G, Kamiya N, Endo I. Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group. In Vivo 2021;35:1217-25. [PMID: 33622924 DOI: 10.21873/invivo.12372] [Reference Citation Analysis]
235 Chen Z, Liu Z, Zhang Y, Wang P, Gao H. Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma. Cancer Manag Res. 2020;12:4475-4482. [PMID: 32606941 DOI: 10.2147/cmar.s255480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
236 Chen Z, Gao W, Pu L, Zhang L, Han G, Zhu Q, Li X, Wu J, Wang X. Impact of insurance status on the survival of gallbladder cancer patients. Oncotarget 2017;8:51663-74. [PMID: 28881677 DOI: 10.18632/oncotarget.18381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
237 Tange S, Hakuta R, Nakai Y, Oyama H, Noguchi K, Ito Y, Bae Y, Kumasaka T, Yoshida H. A rare case of gallbladder cancer with multiple metastases to the colon. Clin J Gastroenterol 2021;14:608-12. [PMID: 33386564 DOI: 10.1007/s12328-020-01301-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Jaruvongvanich V, Assavapongpaiboon B, Wong L. Racial/ethnic disparities in gallbladder cancer receipt of treatments. J Gastrointest Oncol 2018;9:348-53. [PMID: 29755774 DOI: 10.21037/jgo.2017.11.09] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
239 Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 2020;11:871. [PMID: 33067424 DOI: 10.1038/s41419-020-03080-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
240 Shen T, Zheng S, Geng L, Liu Z, Xu J, Lin B, Qian J, Zheng S. Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review. Technol Cancer Res Treat 2020;19:1533033820979703. [PMID: 33308041 DOI: 10.1177/1533033820979703] [Reference Citation Analysis]
241 Li X, Gao L, Qiu M, Cao D. Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 Mutation. Onco Targets Ther 2021;14:2815-9. [PMID: 33911878 DOI: 10.2147/OTT.S303594] [Reference Citation Analysis]
242 Papageorge MV, de Geus SWL, Woods AP, Ng SC, Drake FT, Cassidy MR, McAneny DB, Tseng JF, Sachs TE. Undertreatment of Gallbladder Cancer: A Nationwide Analysis. Ann Surg Oncol 2021;28:2949-57. [PMID: 33566241 DOI: 10.1245/s10434-021-09607-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
243 Yan Y, Lin J, Zhang M, Liu H, Zhou Q, Chen R, Wen K, Wang J, Xiao Z, Mao K. A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer. Front Oncol 2020;10:1281. [PMID: 32850391 DOI: 10.3389/fonc.2020.01281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Tian L, Deng Z, Xu L, Yang T, Yao W, Ji L, Lu Y, Zhang J, Liu Y, Wang J. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway. Cell Death Dis 2018;9:1115. [PMID: 30389910 DOI: 10.1038/s41419-018-1145-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]